MedPath
NMPA Approval

Abatacept Injection

国药准字SJ20200001

November 27, 2024

S20200001

Drug Information

阿巴西普注射液

恩瑞舒

注射剂

125mg(0.95mL)/支(预充式注射器)

生物制品

November 27, 2024

November 26, 2029

Company Information

Applicant Company

PO Box 4000, Princeton, NJ 08543, USA

Manufacturing Company

bristol-myers squibb holdings pharma, ltd. liability company

Road 686 Km 2.3, Bo. Tierras Nuevas, Manati, PUERTO RICO, 00674, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿巴西普注射液 - NMPA 批准文号 | MedPath